BIOMARIN PHARMACEUTICAL INC Investment Income, Interest
BIOMARIN PHARMACEUTICAL INC (BMRN) reported Investment Income, Interest of $10.48 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-06
- BIOMARIN PHARMACEUTICAL INC investment income, interest for the quarter ending 2026-06-30 was $10.48M, a 44.34% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC investment income, interest for the quarter ending 2026-03-31 was $22.56M, a 18.66% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC investment income, interest for the quarter ending 2025-12-31 was $19.21M, a 8.65% increase year-over-year.
- BIOMARIN PHARMACEUTICAL INC investment income, interest for the quarter ending 2025-09-30 was $17.85M, a 1.10% decline year-over-year.
- BIOMARIN PHARMACEUTICAL INC investment income, interest for fiscal 2025 was $74.90M, a 0.03% increase from fiscal 2024.
- BIOMARIN PHARMACEUTICAL INC investment income, interest for fiscal 2024 was $74.88M, a 28.36% increase from fiscal 2023.
- BIOMARIN PHARMACEUTICAL INC investment income, interest for fiscal 2023 was $58.34M, a 223.49% increase from fiscal 2022.
- BIOMARIN PHARMACEUTICAL INC investment income, interest for fiscal 2022 was $18.03M, a 72.05% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.48M 10-Q · filed 2026-08-06 | $33.04M 10-Q · filed 2026-08-06 | $52.25M derived: sum of 3 quarters · filed 2026-08-06 | $70.10M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $22.56M 10-Q · filed 2026-05-05 | $41.77M derived: sum of 2 quarters · filed 2026-05-05 | $59.62M derived: sum of 3 quarters · filed 2026-05-05 | $78.45M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $19.21M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $37.06M derived: sum of 2 quarters · filed 2026-02-26 | $55.89M derived: sum of 3 quarters · filed 2026-08-06 | $74.90M 10-K · filed 2026-02-26 |
| 2025-09-30 | $17.85M 10-Q · filed 2025-10-28 | $36.68M derived: sum of 2 quarters · filed 2026-08-06 | $55.69M 10-Q · filed 2025-10-28 | $73.37M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $18.83M 10-Q · filed 2026-08-06 | $37.84M 10-Q · filed 2026-08-06 | $55.52M derived: sum of 3 quarters · filed 2026-08-06 | $73.57M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $19.01M 10-Q · filed 2026-05-05 | $36.69M derived: sum of 2 quarters · filed 2026-05-05 | $54.75M derived: sum of 3 quarters · filed 2026-05-05 | $74.53M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $17.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $35.73M derived: sum of 2 quarters · filed 2026-02-26 | $55.52M derived: sum of 3 quarters · filed 2026-02-26 | $74.88M 10-K · filed 2026-02-26 |
| 2024-09-30 | $18.05M 10-Q · filed 2025-10-28 | $37.84M derived: sum of 2 quarters · filed 2025-10-28 | $57.20M 10-Q · filed 2025-10-28 | $75.25M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $19.79M 10-Q · filed 2025-08-05 | $39.15M 10-Q · filed 2025-08-05 | $57.19M derived: sum of 3 quarters · filed 2026-02-26 | $72.93M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $19.36M 10-Q · filed 2025-05-02 | $37.41M derived: sum of 2 quarters · filed 2026-02-26 | $53.15M derived: sum of 3 quarters · filed 2026-02-26 | $65.76M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $18.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $33.78M derived: sum of 2 quarters · filed 2026-02-26 | $46.40M derived: sum of 3 quarters · filed 2026-02-26 | $58.34M 10-K · filed 2026-02-26 |
| 2023-09-30 | $15.74M 10-Q · filed 2024-10-31 | $28.35M derived: sum of 2 quarters · filed 2024-10-31 | $40.30M 10-Q · filed 2024-10-31 | $49.01M derived: sum of 4 quarters · filed 2025-02-24 |
| 2023-06-30 | $12.61M 10-Q · filed 2024-08-05 | $24.55M 10-Q · filed 2024-08-05 | $33.27M derived: sum of 3 quarters · filed 2025-02-24 | $38.26M derived: sum of 4 quarters · filed 2025-02-24 |
| 2023-03-31 | $11.94M 10-Q · filed 2024-04-26 | $20.65M derived: sum of 2 quarters · filed 2025-02-24 | $25.65M derived: sum of 3 quarters · filed 2025-02-24 | $28.16M derived: sum of 4 quarters · filed 2025-02-24 |
| 2022-12-31 | $8.71M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | $13.71M derived: sum of 2 quarters · filed 2025-02-24 | $16.21M derived: sum of 3 quarters · filed 2025-02-24 | $18.03M 10-K · filed 2025-02-24 |
| 2022-09-30 | $5.00M 10-Q · filed 2023-11-02 | $7.50M derived: sum of 2 quarters · filed 2023-11-02 | $9.32M 10-Q · filed 2023-11-02 | $11.07M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | $2.50M 10-Q · filed 2023-08-02 | $4.33M 10-Q · filed 2023-08-02 | $6.07M derived: sum of 3 quarters · filed 2024-02-26 | $7.90M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | $1.82M 10-Q · filed 2023-04-28 | $3.56M derived: sum of 2 quarters · filed 2024-02-26 | $5.39M derived: sum of 3 quarters · filed 2024-02-26 | $9.86M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $3.57M derived: sum of 2 quarters · filed 2024-02-26 | $8.04M derived: sum of 3 quarters · filed 2024-02-26 | $10.48M 10-K · filed 2024-02-26 |
| 2021-09-30 | $1.83M 10-Q · filed 2022-10-28 | $6.30M derived: sum of 2 quarters · filed 2022-10-28 | $8.74M 10-Q · filed 2022-10-28 | $11.81M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $4.47M 10-Q · filed 2022-08-04 | $6.91M 10-Q · filed 2022-08-04 | $9.98M derived: sum of 3 quarters · filed 2023-02-27 | $13.98M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $2.44M 10-Q · filed 2022-04-29 | $5.51M derived: sum of 2 quarters · filed 2023-02-27 | $9.51M derived: sum of 3 quarters · filed 2023-02-27 | $13.80M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $7.08M derived: sum of 2 quarters · filed 2023-02-27 | $11.37M derived: sum of 3 quarters · filed 2023-02-27 | $16.61M 10-K · filed 2023-02-27 |
| 2020-09-30 | $4.00M 10-Q · filed 2021-10-29 | $8.29M derived: sum of 2 quarters · filed 2021-10-29 | $13.54M 10-Q · filed 2021-10-29 | $18.75M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-06-30 | $4.29M 10-Q · filed 2021-07-30 | $9.54M 10-Q · filed 2021-07-30 | $14.75M derived: sum of 3 quarters · filed 2022-02-25 | $20.09M derived: sum of 4 quarters · filed 2022-02-25 |
| 2020-03-31 | $5.24M 10-Q · filed 2021-04-30 | $10.46M derived: sum of 2 quarters · filed 2022-02-25 | $15.79M derived: sum of 3 quarters · filed 2022-02-25 | $21.69M derived: sum of 4 quarters · filed 2022-02-25 |
| 2019-12-31 | $5.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $10.55M derived: sum of 2 quarters · filed 2022-02-25 | $16.45M derived: sum of 3 quarters · filed 2022-02-25 | $22.75M 10-K · filed 2022-02-25 |
| 2019-09-30 | $5.34M 10-Q · filed 2020-11-06 | $11.24M derived: sum of 2 quarters · filed 2020-11-06 | $17.54M 10-Q · filed 2020-11-06 | $23.23M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $5.90M 10-Q · filed 2020-08-05 | $12.20M 10-Q · filed 2020-08-05 | $17.89M derived: sum of 3 quarters · filed 2021-02-26 | $24.23M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $6.30M 10-Q · filed 2020-05-01 | $11.99M derived: sum of 2 quarters · filed 2021-02-26 | $18.33M derived: sum of 3 quarters · filed 2021-02-26 | $23.89M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $5.69M derived: 10-K 12 month − 10-Q/A 9 month · filed 2021-02-26 | $12.03M derived: sum of 2 quarters · filed 2021-02-26 | $17.60M derived: sum of 3 quarters · filed 2021-02-26 | $22.83M 10-K · filed 2021-02-26 |
| 2018-09-30 | $6.34M 10-Q/A · filed 2019-11-04 | $11.91M derived: sum of 2 quarters · filed 2019-11-04 | $17.14M 10-Q/A · filed 2019-11-04 | $21.96M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $5.57M 10-Q · filed 2019-08-02 | $10.80M 10-Q · filed 2019-08-02 | $15.63M derived: sum of 3 quarters · filed 2020-02-27 | $19.60M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $5.23M 10-Q · filed 2019-04-29 | $10.06M derived: sum of 2 quarters · filed 2020-02-27 | $14.03M derived: sum of 3 quarters · filed 2020-02-27 | $17.02M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $4.82M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $8.80M derived: sum of 2 quarters · filed 2020-02-27 | $11.78M derived: sum of 3 quarters · filed 2020-02-27 | $14.85M 10-K · filed 2020-02-27 |
| 2017-09-30 | $3.98M 10-Q · filed 2018-10-26 | $6.96M derived: sum of 2 quarters · filed 2018-10-26 | $10.03M 10-Q · filed 2018-10-26 | $12.96M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $2.98M 10-Q · filed 2018-08-03 | $6.05M 10-Q · filed 2018-08-03 | $8.98M derived: sum of 3 quarters · filed 2019-02-28 | $10.61M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $3.07M 10-Q · filed 2018-04-27 | $6.00M derived: sum of 2 quarters · filed 2019-02-28 | $7.63M derived: sum of 3 quarters · filed 2019-02-28 | $8.99M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $2.93M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $4.56M derived: sum of 2 quarters · filed 2019-02-28 | $5.92M derived: sum of 3 quarters · filed 2019-02-28 | $7.49M 10-K · filed 2019-02-28 |
| 2016-09-30 | $1.63M 10-Q · filed 2017-10-31 | $2.99M derived: sum of 2 quarters · filed 2017-10-31 | $4.56M 10-Q · filed 2017-10-31 | $6.01M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $1.36M 10-Q · filed 2017-08-02 | $2.93M 10-Q · filed 2017-08-02 | $4.38M derived: sum of 3 quarters · filed 2018-02-26 | $5.72M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $1.57M 10-Q · filed 2017-05-04 | $3.02M derived: sum of 2 quarters · filed 2018-02-26 | $4.37M derived: sum of 3 quarters · filed 2018-02-26 | $5.39M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $2.79M derived: sum of 2 quarters · filed 2018-02-26 | $3.82M derived: sum of 3 quarters · filed 2018-02-26 | $4.50M 10-K · filed 2018-02-26 |
| 2015-09-30 | $1.34M 10-Q · filed 2016-11-03 | $2.37M derived: sum of 2 quarters · filed 2016-11-03 | $3.05M 10-Q · filed 2016-11-03 | $4.69M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $1.02M 10-Q · filed 2016-08-08 | $1.71M 10-Q · filed 2016-08-08 | $3.35M derived: sum of 3 quarters · filed 2017-02-27 | $4.79M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $683.00K 10-Q · filed 2016-05-02 | $2.33M derived: sum of 2 quarters · filed 2017-02-27 | $3.76M derived: sum of 3 quarters · filed 2017-02-27 | $5.50M derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $3.08M derived: sum of 2 quarters · filed 2017-02-27 | $4.81M derived: sum of 3 quarters · filed 2017-02-27 | $5.94M 10-K · filed 2017-02-27 |
| 2014-09-30 | $1.44M 10-Q · filed 2015-11-02 | $3.17M derived: sum of 2 quarters · filed 2015-11-02 | $4.29M 10-Q · filed 2015-11-02 | $5.43M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $1.74M 10-Q · filed 2015-08-05 | $2.86M 10-Q · filed 2015-08-05 | $4.00M derived: sum of 3 quarters · filed 2016-02-29 | $4.57M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $1.12M 10-Q · filed 2015-05-05 | $2.26M derived: sum of 2 quarters · filed 2016-02-29 | $2.84M derived: sum of 3 quarters · filed 2016-02-29 | $3.49M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.72M derived: sum of 2 quarters · filed 2016-02-29 | $2.37M derived: sum of 3 quarters · filed 2016-02-29 | $3.08M 10-K · filed 2016-02-29 |
| 2013-09-30 | $574.00K 10-Q · filed 2014-10-28 | $1.22M derived: sum of 2 quarters · filed 2014-10-28 | $1.94M 10-Q · filed 2014-10-28 | $2.71M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $650.00K 10-Q · filed 2014-07-31 | $1.37M 10-Q · filed 2014-07-31 | $2.13M derived: sum of 3 quarters · filed 2015-03-02 | $2.91M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $718.00K 10-Q · filed 2014-05-02 | $1.48M derived: sum of 2 quarters · filed 2015-03-02 | $2.26M derived: sum of 3 quarters · filed 2015-03-02 | $2.80M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $765.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $1.54M derived: sum of 2 quarters · filed 2015-03-02 | $2.08M derived: sum of 3 quarters · filed 2015-03-02 | $2.58M 10-K · filed 2015-03-02 |
| 2012-09-30 | $778.00K 10-Q · filed 2013-10-28 | $1.31M derived: sum of 2 quarters · filed 2013-10-28 | $1.82M 10-Q · filed 2013-10-28 | $2.45M derived: sum of 4 quarters · filed 2014-02-26 |
| 2012-06-30 | $536.00K 10-Q · filed 2013-07-29 | $1.04M 10-Q · filed 2013-07-29 | $1.67M derived: sum of 3 quarters · filed 2014-02-26 | $2.40M derived: sum of 4 quarters · filed 2014-02-26 |
| 2012-03-31 | $505.00K 10-Q · filed 2013-04-29 | $1.14M derived: sum of 2 quarters · filed 2014-02-26 | $1.86M derived: sum of 3 quarters · filed 2014-02-26 | $2.66M derived: sum of 4 quarters · filed 2014-02-26 |
| 2011-12-31 | $632.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-26 | $1.35M derived: sum of 2 quarters · filed 2014-02-26 | $2.15M derived: sum of 3 quarters · filed 2014-02-26 | $2.93M 10-K · filed 2014-02-26 |
| 2011-09-30 | $722.00K 10-Q · filed 2012-10-29 | $1.52M derived: sum of 2 quarters · filed 2012-10-29 | $2.30M 10-Q · filed 2012-10-29 | $3.22M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-06-30 | $798.00K 10-Q · filed 2012-08-02 | $1.58M 10-Q · filed 2012-08-02 | $2.50M derived: sum of 3 quarters · filed 2013-02-26 | $3.47M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-03-31 | $782.00K 10-Q · filed 2012-04-30 | $1.70M derived: sum of 2 quarters · filed 2013-02-26 | $2.67M derived: sum of 3 quarters · filed 2013-02-26 | $3.70M derived: sum of 4 quarters · filed 2013-02-26 |
| 2010-12-31 | $919.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $1.89M derived: sum of 2 quarters · filed 2013-02-26 | $2.92M derived: sum of 3 quarters · filed 2013-02-26 | $4.11M 10-K · filed 2013-02-26 |
| 2010-09-30 | $968.00K 10-Q · filed 2011-10-31 | $2.00M derived: sum of 2 quarters · filed 2011-10-31 | $3.19M 10-Q · filed 2011-10-31 | $4.23M derived: sum of 4 quarters · filed 2012-02-22 |
| 2010-06-30 | $1.03M 10-Q · filed 2011-08-01 | $2.23M 10-Q · filed 2011-08-01 | $3.26M derived: sum of 3 quarters · filed 2012-02-22 | $4.27M derived: sum of 4 quarters · filed 2012-02-22 |
| 2010-03-31 | $1.19M 10-Q · filed 2011-04-29 | $2.23M derived: sum of 2 quarters · filed 2012-02-22 | $3.24M derived: sum of 3 quarters · filed 2012-02-22 | $4.12M derived: sum of 4 quarters · filed 2012-02-22 |
| 2009-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-22 | $2.05M derived: sum of 2 quarters · filed 2012-02-22 | $2.93M derived: sum of 3 quarters · filed 2012-02-22 | $5.09M 10-K · filed 2012-02-22 |
| 2009-09-30 | $1.01M 10-Q · filed 2010-10-29 | $1.90M derived: sum of 2 quarters · filed 2010-10-29 | $4.05M 10-Q · filed 2010-10-29 | |
| 2009-06-30 | $886.00K 10-Q · filed 2010-08-04 | $3.04M 10-Q · filed 2010-08-04 | ||
| 2008-12-31 | $16.39M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |